Paperpal, offering an AI-powered assistant for language and technical compliance checks for research manuscripts, has announced a partnership with American Society of Clinical Oncology (ASCO) for its Preflight product. Through this partnership, Preflight will deliver a superior submission experience for authors and help reduce editorial workload at ASCO journals.
Commenting on the partnership, Mads Rydahl, VP Products – Paperpal, said, “Paperpal Preflight provides ASCO’s authors with instant feedback on the submission readiness of their manuscripts. The service allows ASCO’s editors to specify accurate submission requirements for each journal, and Paperpal Preflight then guides authors on where to insert missing declarations and how to correct any grammatical errors before submission. Paperpal Preflight simultaneously eases the burden on editors and improves the life of authors, who often struggle to comply with detailed journal requirements.”
Paperpal Preflight is a plug-and-play web-based application that comes at no additional cost to publishers. This broader publisher-level partnership with ASCO paves the way for other academic publishers to immediately start using the solution without any integration dependency and offer the tool to their submitting authors.
ASCO currently, publishes clinical research on cancer and advances made in patient care. An organization, representing 45,000 oncology professionals, the partnership is the first of several steps towards offering real-time and affordable author support at the point of submission. This will help ASCO’s work to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy.
For more information visit https://paperpal.com/preflight
